Year 2025
Repository
The work of nurses is driving the implementation of biosimilars, which are essential for the sustainability of the healthcare system.
The General Council of Pharmaceutical Colleges and the Spanish Association of Biosimilars (BioSim) held the closing session of the course "Biological and Biosimilar Medicines in Pharmacy," in which the impact of these drugs on the National Health System was analyzed.
In addition, the relationship of the pharmacist with biological and biosimilar medicines has been addressed in four healthcare settings: Community Pharmacy, Pharmaceutical Industry, Hospital Pharmacy and Primary Care Pharmacy
The president of the General Council, Jesús Aguilar, has emphasized that biosimilars are a key element for the balance and sustainability of the National Health System, making it essential to continue advancing their implementation and accessibility.
According to Joaquín Rodrigo, president of BioSim, training in biosimilars is key to empowering pharmacists and improving patient care.
BioSim increases its presence in the Spanish biosimilars market with the addition of Celltrion
The General Council of Pharmaceutical Colleges and the Spanish Association of Biosimilars (BioSim) held the closing session of the course "Biological and Biosimilar Medicines in Pharmacy," in which the impact of these drugs on the National Health System was analyzed.
In addition, the relationship of the pharmacist with biological and biosimilar medicines has been addressed in four healthcare settings: Community Pharmacy, Pharmaceutical Industry, Hospital Pharmacy and Primary Care Pharmacy
The president of the General Council, Jesús Aguilar, has emphasized that biosimilars are a key element for the balance and sustainability of the National Health System, making it essential to continue advancing their implementation and accessibility.
According to Joaquín Rodrigo, president of BioSim, training in biosimilars is key to empowering pharmacists and improving patient care.
The “Mucha Vida” biosimilars for patients, healthcare professionals, administration and the pharmaceutical industry
The General Council of Pharmaceutical Colleges and the Spanish Association of Biosimilars (BioSim) held the closing session of the course "Biological and Biosimilar Medicines in Pharmacy," in which the impact of these drugs on the National Health System was analyzed.
In addition, the relationship of the pharmacist with biological and biosimilar medicines has been addressed in four healthcare settings: Community Pharmacy, Pharmaceutical Industry, Hospital Pharmacy and Primary Care Pharmacy
The president of the General Council, Jesús Aguilar, has emphasized that biosimilars are a key element for the balance and sustainability of the National Health System, making it essential to continue advancing their implementation and accessibility.
According to Joaquín Rodrigo, president of BioSim, training in biosimilars is key to empowering pharmacists and improving patient care.
BioSim's second Horizon Scanning update anticipates the commercialization of three new biosimilars in 2025.
The General Council of Pharmaceutical Colleges and the Spanish Association of Biosimilars (BioSim) held the closing session of the course "Biological and Biosimilar Medicines in Pharmacy," in which the impact of these drugs on the National Health System was analyzed.
In addition, the relationship of the pharmacist with biological and biosimilar medicines has been addressed in four healthcare settings: Community Pharmacy, Pharmaceutical Industry, Hospital Pharmacy and Primary Care Pharmacy
The president of the General Council, Jesús Aguilar, has emphasized that biosimilars are a key element for the balance and sustainability of the National Health System, making it essential to continue advancing their implementation and accessibility.
According to Joaquín Rodrigo, president of BioSim, training in biosimilars is key to empowering pharmacists and improving patient care.
Pharmacists highlight the potential of biological and biosimilar medicines to improve patient care
The General Council of Pharmaceutical Colleges and the Spanish Association of Biosimilars (BioSim) held the closing session of the course "Biological and Biosimilar Medicines in Pharmacy," in which the impact of these drugs on the National Health System was analyzed.
In addition, the relationship of the pharmacist with biological and biosimilar medicines has been addressed in four healthcare settings: Community Pharmacy, Pharmaceutical Industry, Hospital Pharmacy and Primary Care Pharmacy
The president of the General Council, Jesús Aguilar, has emphasized that biosimilars are a key element for the balance and sustainability of the National Health System, making it essential to continue advancing their implementation and accessibility.
According to Joaquín Rodrigo, president of BioSim, training in biosimilars is key to empowering pharmacists and improving patient care.